Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_581ae3a68286af10919b25930e1f2e34 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 |
filingDate |
2019-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6ea169fbc0c6600b2e5a3496f7adfbd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d3fb3becdd89618f6126ac36b2bc681 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81b7f50ae0bf41ea1586ec104847a8ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c70b25c92a7af6ed28b784096d553c22 |
publicationDate |
2020-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TW-I693068-B |
titleOfInvention |
Use of nerolidol for manufacturing compositions for treating acute lung injury |
abstract |
The invention relates to a use of nerolidol for manufacturing compositions for treating acute lung injury. It comprises administrating an effective dose of nerolidol to a subject in need for reducing hyaline membrane formation, neutrophil infiltration, lung edema and oxidative stresses so as to achieve efficacy of treating acute lung injury. |
priorityDate |
2019-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |